ResMed Inc (RMD)
248.42
+2.79
(+1.14%)
USD |
NYSE |
Nov 07, 16:00
248.47
+0.05
(+0.02%)
After-Hours: 20:00
ResMed Revenue (Annual): 4.685B for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.685B |
| June 30, 2023 | 4.223B |
| June 30, 2022 | 3.578B |
| June 30, 2021 | 3.197B |
| June 30, 2020 | 2.957B |
| June 30, 2019 | 2.607B |
| June 30, 2018 | 2.340B |
| June 30, 2017 | 2.067B |
| June 30, 2016 | 1.839B |
| June 30, 2015 | 1.679B |
| June 30, 2014 | 1.555B |
| June 30, 2013 | 1.514B |
| June 30, 2012 | 1.369B |
| June 30, 2011 | 1.243B |
| June 30, 2010 | 1.092B |
| June 30, 2009 | 920.74M |
| Date | Value |
|---|---|
| June 30, 2008 | 835.40M |
| June 30, 2007 | 716.33M |
| June 30, 2006 | 607.00M |
| June 30, 2005 | 425.50M |
| June 30, 2004 | 339.34M |
| June 30, 2003 | 273.57M |
| June 30, 2002 | 204.08M |
| June 30, 2001 | 155.16M |
| June 30, 2000 | 115.62M |
| June 30, 1999 | 88.60M |
| June 30, 1998 | 66.50M |
| June 30, 1997 | 49.20M |
| June 30, 1996 | 34.60M |
| June 30, 1995 | 23.50M |
| June 30, 1994 | 13.90M |
| June 30, 1993 | 7.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.957B
Minimum
2020
4.685B
Maximum
2024
3.728B
Average
3.578B
Median
2022
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Abbott Laboratories | 40.11B |
| Becton Dickinson & Co | 19.37B |
| Insulet Corp | 1.697B |
| Twist Bioscience Corp | 245.11M |